HR 742
Protects act of 2025
Protects Act of 2025
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Bill overview
This bill, titled the PROTECTS Act of 2025, prohibits the use of federal funds for certain gender transition procedures performed on individuals under the age of 18. Specifically, it restricts funding for surgeries, medications, and implants intended to alter a person’s body to no longer align with their biological sex. However, the bill includes exceptions for treatments related to genetic disorders or conditions posing an imminent threat to life or bodily function, with parental consent required in those cases.
Key provisions
- Prohibits federal funds from being used for gender transition procedures on individuals under 18.
- Defines ‘specified gender transition procedure’ to include surgeries, medications, and implants altering body features.
- Excludes puberty suppression drugs for precocious puberty.
- Allows treatments for genetic disorders of sex development with parental consent.
- Permits procedures to address medically verifiable genetic anomalies or hormonal imbalances.
- Includes exceptions for treating imminent death or impairment of a major bodily function.
- Defines ‘sex’ as biologically determined male or female.
- Specifies ‘female’ and ‘male’ definitions for legal purposes.
Who is affected
- Minors seeking gender transition care
- Healthcare providers offering gender transition services
- Federal agencies administering healthcare funds
- Parents or legal guardians of minors
- Individuals with genetic disorders of sex development
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsors
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.
119th CONGRESS — 1st Session
H. R. 742
IN THE HOUSE OF REPRESENTATIVES
A BILL
To prohibit Federal funds from being used to provide certain gender transition procedures to minors.
This Act may be cited as the Protecting Resources Of Taxpayers to Eliminate Childhood Transgender Surgeries Act of 2025 PROTECTS Act of 2025
or the
.
Notwithstanding any other provision of law, no Federal funds may be used or otherwise made available to provide or refer for a specified gender transition procedure to an individual under the age of 18 or to reimburse any entity for providing such a procedure to such an individual.
For purposes of this paragraph, except as provided in paragraph (2), the term specified gender transition procedure
means, with respect to an individual, any of the following when performed for the purpose of intentionally changing the body of such individual to no longer correspond to their sex:
Performing any surgery, including—
castration;
orchiectomy;
scrotoplasty;
vasectomy;
hysterectomy;
oophorectomy;
ovariectomy;
metoidioplasty;
penectomy;
phalloplasty;
vaginoplasty;
vaginectomy;
vulvoplasty;
reduction thyrochondroplasty;
chondrolaryngoplasty;
mastectomy; and
any plastic, cosmetic, or aesthetic surgery that feminizes or masculinizes the facial or other body features of an individual.
Any placement of chest implants to create feminine breasts.
Any placement of fat or artificial implants in the gluteal region.
Administering, supplying, prescribing, dispensing, distributing, or otherwise conveying to an individual medications, including—
gonadotropin-releasing hormone (GnRH) analogues or other puberty-blocking drugs to stop or delay normal puberty; and
Paragraph (1) shall not apply to the following when furnished to an individual by a health care provider with the consent of such individual’s parent or legal guardian:
Puberty suppression or blocking prescription drugs for the purpose of normalizing puberty for an individual experiencing precocious puberty.
Appropriate and medically necessary procedures or treatments to correct for—
a medically verifiable genetic disorder of sex development, including—
46,XX chromosomes with virilization;
46,XY chromosomes with undervirilization; and
both ovarian and testicular tissue;
sex chromosome structure, sex steroid hormone production, or sex hormone action, if determined to be abnormal by a physician through genetic or biochemical testing; or
infection, disease, injury, or disorder caused or exacerbated by a previous procedure described in paragraph (1), or a physical disorder, physical injury, or physical illness that would, as certified by a physician, place the individual in imminent danger of death or impairment of a major bodily function unless the procedure is performed, not including procedures performed for the alleviation of mental distress.
For purposes of this section:
sex, when referring to individual’s sex, shall be understood to refer to either male or female, as biologically determined.
female, when referring to a natural person, means an individual who naturally has, had, will have, or would have, but for a developmental or genetic anomaly or historical accident, the reproductive system that at some point produces, transports, and utilizes eggs for fertilization.
male, when referring to a natural person, means an individual who naturally has, had, will have, or would have, but for a developmental or genetic anomaly or historical accident, the reproductive system that at some point produces, transports, and utilizes sperm for fertilization.